Avatar Medical and Kyber announced on October 1, 2026, that they have secured a grant of up to €3.7 million under the French government's France 2030 program to develop Avatar MediVerse, a project designed to make immersive, personalized imaging available wherever clinicians and patients need it. The full announcement, including downloadable images and bios, can be viewed by clicking here.
The significance of this funding lies in its potential to transform how medical imaging is accessed and used in hospitals. Currently, immersive 3D visualization often requires dedicated rooms and specialized equipment, limiting its availability. Avatar MediVerse aims to break those constraints by making interactive 3D anatomy accessible wherever it can be useful in the surgical journey. This means clinicians and patients could rely on the same personalized 3D representation of a patient's anatomy from consultation to surgical planning and into the operating room, ensuring consistency and improving communication.
The project combines the expertise of two French deeptech companies. Avatar Medical brings its know-how in 3D medical visualization, while Kyber contributes its specialization in ultra-low latency extended reality (XR) streaming and remote rendering. Kyber is a commercial spin-off of KLabs, the company hosting the VideoLAN project, creators of VLC, one of the world's most widely used open-source media players. Kyber develops real-time infrastructures for healthcare, robotics, cloud rendering, and AI-driven video applications. More information is available at https://kyber.tech.
Avatar Medical, founded in 2020, is a pioneer in visual intelligence for surgery. Its flagship solution, Avatar Medical Vision, instantly transforms CT scans and MRIs into interactive, realistic 3D visualizations without segmentation, providing clinicians with a more intuitive way to understand each patient's specific anatomy, plan interventions, collaborate, and communicate with patients. The company's technology, originating from research at Institut Curie and Institut Pasteur, is FDA-cleared and CE-marked and is used in collaboration with more than 20 hospitals in the United States and Europe. Learn more at avatarmedical.ai.
For the healthcare industry, this development could signal a shift toward more widespread adoption of immersive 3D imaging, potentially improving surgical outcomes and patient engagement. By enabling the same visual information throughout the care pathway, MediVerse could reduce miscommunication and enhance decision-making. The France 2030 grant underscores the government's commitment to supporting innovative deeptech solutions that address real-world challenges in healthcare. As Avatar Medical and Kyber work to develop Avatar MediVerse, the impact may extend beyond France, offering a scalable model for hospitals worldwide. The source of this announcement is Avatar Medical, distributed by Reportable, Inc..
